Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Joubert, Michaël"" wg kryterium: Autor


Tytuł :
Hyperglycemia-Induced Hypovolemia Is Involved in Early Cardiac Magnetic Resonance Alterations in Streptozotocin-Induced Diabetic Mice: A Comparison with Furosemide-Induced Hypovolemia.
Autorzy :
Joubert M; Diabetes care unit, Caen University Hospital, Caen, France.; EA4650 Université Caen Normandie, GIP Cyceron, Caen, France.
Bellevre D; Nuclear Medicine department, Caen University Hospital, Caen, France.; EA4650 Université Caen Normandie, GIP Cyceron, Caen, France.
Legallois D; Cardiology unit, Caen University Hospital, Caen, France.; EA4650 Université Caen Normandie, GIP Cyceron, Caen, France.
Elie N; CMABIO-HIQ facility, SF4206 ICORE, IBFA, Université Caen Normandie, Caen, France.
Coulbault L; Biochemical unit, Caen University Hospital, Caen, France.; EA4650 Université Caen Normandie, GIP Cyceron, Caen, France.
Allouche S; Biochemical unit, Caen University Hospital, Caen, France.; EA4650 Université Caen Normandie, GIP Cyceron, Caen, France.
Manrique A; Nuclear Medicine department, Caen University Hospital, Caen, France.; EA4650 Université Caen Normandie, GIP Cyceron, Caen, France.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2016 Feb 22; Vol. 11 (2), pp. e0149808. Date of Electronic Publication: 2016 Feb 22 (Print Publication: 2016).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiac Imaging Techniques*
Furosemide*
Magnetic Resonance Imaging*
Diabetes Mellitus, Experimental/*physiopathology
Hyperglycemia/*complications
Hyperglycemia/*physiopathology
Hypovolemia/*chemically induced
Hypovolemia/*complications
Animals ; Diabetes Mellitus, Experimental/pathology ; Hyperglycemia/pathology ; Hypovolemia/pathology ; Male ; Mice
Czasopismo naukowe
Tytuł :
Sustained Efficacy of Insulin Pump Therapy in Type 2 Diabetes: 9-Year Follow-up in a Cohort of 161 Patients.
Autorzy :
Morera J; Department of Endocrinology, University of Caen, Côte de Nacre Regional Hospital Center, Caen, France.
Joubert M; Department of Endocrinology, University of Caen, Côte de Nacre Regional Hospital Center, Caen, France.
Morello R; Department of Statistics, University of Caen, Côte de Nacre Regional Hospital Center, Caen, France.
Rod A; Department of Endocrinology, University of Caen, Côte de Nacre Regional Hospital Center, Caen, France.
Lireux B; Department of Endocrinology, University of Caen, Côte de Nacre Regional Hospital Center, Caen, France.
Reznik Y; Department of Endocrinology, University of Caen, Côte de Nacre Regional Hospital Center, Caen, France .
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2016 Jun; Vol. 39 (6), pp. e74-5. Date of Electronic Publication: 2016 Apr 08.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
Raport
Tytuł :
Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
Autorzy :
Clergeau A; 1 Diabetes Care Unit, University Hospital of Caen , Caen, France .
Parienti JJ; 2 Biostatistic Unit, University Hospital of Caen , Caen, France .
Reznik Y; 1 Diabetes Care Unit, University Hospital of Caen , Caen, France .
Clergeau D; 3 Intensive Care Unit, University Hospital of Caen , Caen, France .
Seguin A; 3 Intensive Care Unit, University Hospital of Caen , Caen, France .
Valette X; 3 Intensive Care Unit, University Hospital of Caen , Caen, France .
du Cheyron D; 3 Intensive Care Unit, University Hospital of Caen , Caen, France .
Joubert M; 1 Diabetes Care Unit, University Hospital of Caen , Caen, France .
Pokaż więcej
Źródło :
Diabetes technology & therapeutics [Diabetes Technol Ther] 2017 Feb; Vol. 19 (2), pp. 115-123.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Glucose/*analysis
Hyperglycemia/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosage
Aged ; Critical Care/methods ; Female ; Humans ; Hyperglycemia/blood ; Hypoglycemic Agents/therapeutic use ; Infusions, Intravenous ; Insulin/therapeutic use ; Insulin Infusion Systems ; Intensive Care Units ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Autorzy :
Joubert M; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.; Endocrinologie, CHU Caen, Caen, France.; EA 4650, UNICAEN, GIP Cyceron, Caen, France.
Jagu B; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Montaigne D; Universite Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-European Genomic Institute for Diabetes, Lille, France.
Marechal X; Universite Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-European Genomic Institute for Diabetes, Lille, France.
Tesse A; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Ayer A; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Dollet L; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Le May C; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Toumaniantz G; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Manrique A; EA 4650, UNICAEN, GIP Cyceron, Caen, France.
Charpentier F; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Staels B; Universite Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-European Genomic Institute for Diabetes, Lille, France.
Magré J; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.
Cariou B; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, CHU Nantes, Nantes, France.
Prieur X; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France .
Pokaż więcej
Źródło :
Diabetes [Diabetes] 2017 Apr; Vol. 66 (4), pp. 1030-1040. Date of Electronic Publication: 2017 Jan 04.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetic Cardiomyopathies*
Lipodystrophy*/genetics
Benzhydryl Compounds/*pharmacology
Diabetes Mellitus, Type 2/*drug therapy
Glucosides/*pharmacology
Heart/*drug effects
Hypoglycemic Agents/*pharmacology
Thiazolidinediones/*pharmacology
Ventricular Function/*drug effects
Animals ; Benzhydryl Compounds/therapeutic use ; Blood Glucose/metabolism ; Cardiomyopathy, Hypertrophic ; Diabetes Mellitus, Type 2/genetics ; Diabetes Mellitus, Type 2/metabolism ; Disease Models, Animal ; Echocardiography ; Fluorodeoxyglucose F18 ; GTP-Binding Protein gamma Subunits ; Glucosides/therapeutic use ; Heart/diagnostic imaging ; Heterotrimeric GTP-Binding Proteins/genetics ; Hyperglycemia ; Hypoglycemic Agents/therapeutic use ; Magnetic Resonance Imaging ; Mice ; Mice, Knockout ; Myocardium/metabolism ; Pioglitazone ; Positron-Emission Tomography ; Radiopharmaceuticals ; Sodium-Glucose Transporter 2 Inhibitors ; Ventricular Dysfunction, Left
Czasopismo naukowe
Tytuł :
Test-retest reproducibility of cardiac magnetic resonance imaging in healthy mice at 7-Tesla: effect of anesthetic procedures.
Autorzy :
Joubert M; EA4650, Université de Caen Normandie, 14000, Caen, France. joubert.; Diabetes Care Unit, CHU de Caen, 14000, Caen, France. joubert.
Tager P; EA4650, Université de Caen Normandie, 14000, Caen, France.; Nuclear Medicine, CHU de Caen, 14000, Caen, France.
Legallois D; EA4650, Université de Caen Normandie, 14000, Caen, France.; Cardiology, CHU de Caen, 14000, Caen, France.
Defourneaux E; EA4650, Université de Caen Normandie, 14000, Caen, France.
Le Guellec B; EA4650, Université de Caen Normandie, 14000, Caen, France.
Gerber B; Cardiology, Université Catholique de Louvain, B-1348, Louvain-la-Neuve Brussels, Belgium.
Morello R; Biostatistic, CHU de Caen, 14000, Caen, France.
Manrique A; EA4650, Université de Caen Normandie, 14000, Caen, France.; Nuclear Medicine, CHU de Caen, 14000, Caen, France.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2017 Jul 27; Vol. 7 (1), pp. 6698. Date of Electronic Publication: 2017 Jul 27.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging*
Anesthetics/*pharmacology
Heart/*diagnostic imaging
Animals ; Diastole/drug effects ; Diastole/physiology ; Heart Function Tests ; Male ; Mice, Inbred C57BL ; Myocardium/cytology ; Reproducibility of Results ; Systole/drug effects ; Systole/physiology
Czasopismo naukowe
Tytuł :
[At the heart of diabetic cardiomyopathy: Bscl2 knockout mice to investigate glucotoxicity].
Autorzy :
Lugat A; Institut du thorax, Inserm, CNRS, univ Nantes, CHU Nantes, 8, quai Moncousu, Nantes, F-44000, France.
Joubert M; Service Endocrinologie, CHU de Caen, Caen, F-14003, France - EA4650 - Unicaen - GIP Cyceron - Caen, Caen, F-14074, France.
Cariou B; Institut du thorax, Inserm, CNRS, univ Nantes, CHU Nantes, 8, quai Moncousu, Nantes, F-44000, France.
Prieur X; Institut du thorax, Inserm, CNRS, univ Nantes, Nantes, F-44000, France.
Pokaż więcej
Transliterated Title :
Au cœur de la cardiomyopathie diabétique - Les souris lipodystrophiques SKO comme modèle d’étude de la glucotoxicité.
Źródło :
Medecine sciences : M/S [Med Sci (Paris)] 2018 Jun-Jul; Vol. 34 (6-7), pp. 563-570. Date of Electronic Publication: 2018 Jul 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Blood Glucose/*physiology
Diabetes Mellitus, Type 2/*complications
Diabetes Mellitus, Type 2/*genetics
Diabetic Cardiomyopathies/*genetics
Heterotrimeric GTP-Binding Proteins/*genetics
Animals ; Benzhydryl Compounds/therapeutic use ; Cardiotoxicity/genetics ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/drug therapy ; Diabetic Cardiomyopathies/pathology ; Diabetic Cardiomyopathies/prevention & control ; GTP-Binding Protein gamma Subunits/antagonists & inhibitors ; GTP-Binding Protein gamma Subunits/genetics ; Glucosides/therapeutic use ; Heterotrimeric GTP-Binding Proteins/antagonists & inhibitors ; Humans ; Mice ; Mice, Knockout
Czasopismo naukowe
Tytuł :
Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial.
Autorzy :
Reznik Y; Department of Endocrinology and Diabetology, Côte de Nacre Regional Hospital Center, Caen, France.; University of Caen Basse-Normandie, Medical School, Caen, France.
Habteab A; Medtronic Bakken Research Center, Maastricht, The Netherlands.
Castaneda J; Medtronic Bakken Research Center, Maastricht, The Netherlands.
Shin J; Medtronic Diabetes, Northridge, California.
Joubert M; Department of Endocrinology and Diabetology, Côte de Nacre Regional Hospital Center, Caen, France.; University of Caen Basse-Normandie, Medical School, Caen, France.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Oct; Vol. 20 (10), pp. 2435-2441. Date of Electronic Publication: 2018 Jul 06.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Insulin Infusion Systems*/standards
Diabetes Mellitus, Type 2/*drug therapy
Hyperglycemia/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosage
Adult ; Aged ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Blood Glucose Self-Monitoring/instrumentation ; Blood Glucose Self-Monitoring/methods ; Blood Glucose Self-Monitoring/standards ; Calibration ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Dose-Response Relationship, Drug ; Drug Substitution ; Female ; Glycated Hemoglobin A/drug effects ; Glycated Hemoglobin A/metabolism ; Humans ; Hyperglycemia/complications ; Male ; Middle Aged ; Postprandial Period/drug effects
Czasopismo naukowe
Tytuł :
Quality of Life but not Cognition is Impacted by Radiotherapy in Patients with Non-Functioning Pituitary Adenoma.
Autorzy :
Crouzeix G; Department of Endocrinology, University Hospital of Brest, Brest Cedex, France.
Morello R; Department of Biostatistics and Clinical Research, Caen Cedex, France.
Thariat J; Department of Radiation Oncology, Baclesse Cancer Center, Caen Cedex, France.
Morera J; Department of Endocrinology and Diabetology, University Hospital of Caen, Caen Cedex, France.
Joubert M; Department of Endocrinology and Diabetology, University Hospital of Caen, Caen Cedex, France.; University of Caen, Medical School, Caen, France.
Reznik Y; Department of Endocrinology and Diabetology, University Hospital of Caen, Caen Cedex, France.; University of Caen, Medical School, Caen, France.
Pokaż więcej
Źródło :
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme [Horm Metab Res] 2019 Mar; Vol. 51 (3), pp. 178-185. Date of Electronic Publication: 2019 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Adenoma/*radiotherapy
Cognition/*physiology
Pituitary Neoplasms/*radiotherapy
Quality of Life/*psychology
Radiotherapy/*psychology
Adenoma/psychology ; Adult ; Aged ; Cognition Disorders/etiology ; Cognition Disorders/psychology ; Female ; Humans ; Male ; Middle Aged ; Neuropsychological Tests ; Pituitary Neoplasms/psychology ; Radiotherapy/adverse effects ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
Autorzy :
Benhamou PY; Department of Endocrinology, Grenoble University Hospital, INSERM U1055, Grenoble Alpes University, Grenoble, France. Electronic address: .
Franc S; Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.
Reznik Y; Department of Endocrinology, University of Caen Côte de Nacre Regional Hospital Center, Caen, France.
Thivolet C; Department of Endocrinology, Diabetology, Nutrition, Hospices Civils de Lyon, Lyon, France.
Schaepelynck P; Department of Diabetology, Marseille University Hospital, Marseille, France.
Renard E; Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, UMR CNRS 5203, INSERM U1191, University of Montpellier, Montpellier, France.
Guerci B; Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Lorraine University Hospital, Vandoeuvre Lès Nancy, France.
Chaillous L; Department of Endocrinology, Diabetology, Nutrition, L'Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Lukas-Croisier C; Department of Endocrinology, Diabetology, Reims University Hospital, Reims, France.
Jeandidier N; Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospital, Strasbourg, France.
Hanaire H; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Borot S; Department of Endocrinology, Nutrition and Diabetes, Besançon University Hospital and Franche-Comté University, Besançon, France.
Doron M; Laboratoire d'électronique des technologies de l'information, F-38000, Grenoble Alpes University, Grenoble, France.
Jallon P; Laboratoire d'électronique des technologies de l'information, F-38000, Grenoble Alpes University, Grenoble, France.
Xhaard I; Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.
Melki V; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Meyer L; Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospital, Strasbourg, France.
Delemer B; Department of Endocrinology, Diabetology, Reims University Hospital, Reims, France.
Guillouche M; Department of Endocrinology, Diabetology, Nutrition, L'Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Schoumacker-Ley L; Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Lorraine University Hospital, Vandoeuvre Lès Nancy, France.
Farret A; Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, UMR CNRS 5203, INSERM U1191, University of Montpellier, Montpellier, France.
Raccah D; Department of Diabetology, Marseille University Hospital, Marseille, France.
Lablanche S; Department of Endocrinology, Grenoble University Hospital, INSERM U1055, Grenoble Alpes University, Grenoble, France.
Joubert M; Department of Endocrinology, University of Caen Côte de Nacre Regional Hospital Center, Caen, France.
Penfornis A; Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Paris Sud University, Paris, France.
Charpentier G; Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.
Pokaż więcej
Corporate Authors :
DIABELOOP WP7 Trial Investigators
Źródło :
The Lancet. Digital health [Lancet Digit Health] 2019 May; Vol. 1 (1), pp. e17-e25. Date of Electronic Publication: 2019 May 02.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Insulin Infusion Systems*
Diabetes Mellitus, Type 1/*drug therapy
Glycated Hemoglobin A/*analysis
Hypoglycemia/*prevention & control
Hypoglycemic Agents/*therapeutic use
Insulin/*therapeutic use
Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies